Angelini Pharma to acquire Arvelle Therapeutics in $960 million deal
January 6, 2021Research and Development Angelini Pharma, central nervous system
Angelini Pharma is set to acquire Arvelle Therapeutics, a biopharmaceutical company focused on bringing innovative treatments to patients suffering from …
AstraZeneca’s Farxiga granted Priority Review by FDA
January 6, 2021Research and Development AstraZeneca, FDA, farxiga
AstraZeneca’s Farxiga (dapagliflozin) has been granted Priority Review in the US for the treatment of new or worsening chronic kidney …
Clinigen appoints Sam Herbert as Chief Operating Officer
January 5, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Clinigen, the global pharmaceutical and services company, has appointed Sam Herbert as Chief Operating Officer with immediate effect.
PureTech appoints George Farmer as Chief Financial Officer
January 5, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
PureTech Health, a clinical-stage biotherapeutics company focused on highly differentiated medicines for devastating diseases, has appointed Dr George Farmer as …
Sosei Heptares to regain rights to muscarinic agonist programmes
January 5, 2021Manufacturing and Production Sosei Heptares
Biopharmaceutical group Sosei Heptares has announced it is to regain the worldwide rights to its muscarinic agonist programmes, after they …
Israel authorises Moderna’s COVID-19 vaccine for use
January 5, 2021Manufacturing and Production COVID-19, Moderna, Vaccine
Moderna has announced that Israel’s Ministry of Health (MOH) has authorised the use of its COVID-19 vaccine. Israel has secured …
Genentech’s cancer drug gets Breakthrough Therapy Designation from FDA
January 5, 2021Manufacturing and Production Cancer, Genentech
Genentech has announced that tiragolumab, a novel cancer immunotherapy designed to bind to T cell immunoreceptor with Ig and ITIM …
Emergex to collaborate with Bio-Manguinhos on new COVID-19 vaccine
January 5, 2021Manufacturing and Production COVID-19, Vaccine
Emergex, a company focusing on the development of medicines against viral and bacterial infectious diseases, has announced a collaboration and …
Scientists develop new drug to target KRAS mutations in cancer
January 5, 2021Manufacturing and Production Cancer, Cancer Research UK
In a study funded by Cancer Research UK and Wellcome, scientists have developed a new drug that effectively targets the …
EU states to receive 100m extra doses of Pfizer-BioNTech vaccine
January 4, 2021Sales and Marketing COVID-19, EU, Pfizer, Vaccine
Pfizer and BioNTech have announced they will supply an additional 100 million doses of their COVID-19 vaccine, COMIRNATY, to the …
Concern as India approves COVID-19 vaccine before trial completion
January 4, 2021Sales and Marketing COVID-19, Vaccine
Experts have expressed concern over India’s emergency approval of its homegrown COVID-19 vaccine, Covaxin, before studies have been completed. The …
Moderna’s COVID-19 vaccine achieves over 90% efficacy in Phase III trial
January 4, 2021Sales and Marketing COVID-19, Moderna
Moderna’s COVID-19 vaccine has achieved over 90% efficacy in interim safety and primary efficacy results following its Phase III trial. …
RedHill announces positive top-line data for COVID-19 pneumonia drug
January 4, 2021Sales and Marketing COVID-19
RedHill Biopharma has announced that preliminary top-line data from its US Phase II study with orally-administered opaganib (Yeliva) in patients …
UK becomes first country to roll out Oxford University-AstraZeneca COVID-19 vaccine
January 4, 2021Sales and Marketing AstraZeneca, COVID-19, Vaccine
The UK has become the first country to administer the Oxford University-AstraZeneca COVID-19 vaccine to its population as coronavirus case …
Pharmafile.com’s top 10 stories of 2020
December 23, 2020Research and Development
The COVID-19 pandemic has, unsurprisingly, dominated the news this year. The site’s most popular articles of 2020, focused largely on …
BioInvent receives $3m payment for antibodies selected by Pfizer
December 23, 2020Research and Development BioInvent, Cancer, Pfizer
BioInvent International, a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, …
Zogenix gets EU marketing authorisation for anti-seizure drug
December 23, 2020Research and Development
The European Commission (EC) has granted marketing authorisation for Zogenix’s FINTEPLA (fenfluramine), an oral solution for the treatment of seizures …
Pharmafile.com’s weekly COVID-19 news round-up
December 23, 2020Research and Development COVID-19, Vaccine
The United States’ mission to inoculate its population is well underway this week; not only has the FDA given emergency …
Vicore Pharma study suggests C21 could complement COVID-19 vaccines
December 23, 2020Research and Development COVID-19, Vicore Pharma
Vicore Pharma, a Swedish company focused on developing medicines for severe lung disorders, has published data suggesting that its oral …
Novavax appoints Rick Crowley as Executive Vice President, Chief Operations Officer.
December 22, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Novavax, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has announced the appointment of Rick Crowley to …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
